General

The European Medicines Agency has developed the ‘Electronic Register of studies’ to provide a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies. The main purposes of this electronic register are to reduce publication bias, to increase transparency, to promote information exchange and to facilitate collaborations within the scientific community.

Registration of studies in the electronic register is mandatory only for “ENCePP studies” before the study commences; it is voluntary for all other studies.

Registration of studies

As the (Primary) lead investigator, when you register your study, or provide subsequent updates to existing database entries, you confirm that this information is true, accurate, current and complete. You agree that ENCePP may use the information you provide to us according to the Privacy Policy on our Website.

If you register your study with the ENCePP Electronic Register of studies, you agree to accept responsibility for all activities that occur under your account or password.

It is your responsibility as (Primary) lead investigator to enter your own information and to keep this information up-to-date at all times. By submitting an application to be included in Electronic Register of Studies, you commit to reviewing and updating your database entry(ies) regularly.

By submitting data on your study, you acknowledge that all information is accessible to the public at the ENCePP website.

The ENCePP Secretariat reserves the right to reject any submission for registration deemed incomplete or inadequate. An acknowledgement will be dispatched within two weeks of submission.